NK cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT.
Kanold J, Paillard C, Tchirkov A, Lang P, Kelly A, Halle P, Isfan F, Merlin E, Marabelle A, Rochette E, Deméocq F.
Kanold J, et al. Among authors: tchirkov a.
Pediatr Blood Cancer. 2012 Oct;59(4):739-42. doi: 10.1002/pbc.24030. Epub 2011 Dec 16.
Pediatr Blood Cancer. 2012.
PMID: 22180305